Edgewise Therapeutics, Inc. — Form D
Edgewise Therapeutics, Inc. of Boulder, CO, a company, filed a Form D exempt-offering notice with the SEC on 2019-09-26. The offering totals $50.1M, of which $25.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-09-26
- Form: D
- Accession: 0001710072-19-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $50.1M
- Amount sold: $25.1M
- Remaining: $25.1M
- Investors: 6
- Date of first sale: 2019-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-349663
Issuer
- Name: Edgewise Therapeutics, Inc.
- CIK: 0001710072
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3415 Colorado Ave, Boulder, CO, 80303
- Phone: (303) 735-8373
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jonathan Root | Director | Aliso Viejo, CA |
| Kenneth Harrison | Director | Half Moon Bay, CA |
| Peter Thompson | Director | Chanhassen, MN |
| KEVIN KOCH | Director | WOBURN, MA |
| KEVIN KOCH | Executive Officer | WOBURN, MA |
| Alan Russell | Director | Boulder, CO |
Other filings by this issuer (1)
More